Rendong Bio (688193)
SSE · 688193
Market Cap$1.9B
Revenue$163.5M
Listed OnSSE
Ticker688193
CEO / ExecMr. Jinliang Ju
HeadquartersShanghai
MarketMainland China
Websitewww.rdbio.com
Overview
Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.